Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001140361-16-048539
Filing Date
2016-01-25
Accepted
2016-01-25 14:38:55
Documents
1
Effectiveness Date
2016-01-25
Items
Item 06c:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 12574
  Complete submission text file 0001140361-16-048539.txt   13731
Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-255885 | Film No.: 161358558
SIC: 2834 Pharmaceutical Preparations